Europe Radiotherapy Market: By Equipment (Radiation therapy stimulators, Treatment planning systems, Linear Accelerators), By Type (External Therapy, Intensity Modulated Therapy, External Beam Therapy, Image-guided Radiation Therapy, Stereotactic Body Radiation Therapy, Intraoperative Radiation Therapy, Electron Therapy, Proton Therapy, Tomotherapy, Internal Therapy, Brachytherapy, Radioisotope or Radionuclide Therapy, Radioembolization), By Application (Skin And Lip Cancer, Head and Neck Cancer, Breast Cancer, Prostate Cancer, Cervical Cancer, Lung Cancer, Spine Cancer), By End User (Hospitals, Oncology centers, R&D centers, Diagnostic centers) and Country  

Purchase Option

$ 3000
$ 4400
$ 4600
$ 6900

Europe Radiotherapy Market size was valued at USD 5,650.2 million in 2022 and is poised to grow at a CAGR of 3.8% from 2023-2029. Europe Radiotherapy Market is a painless treatment which is extensively used in cancer treatment. It works on the principle of damaging cancerous cells by destruction of DNA inside cells by radiation. It slows down the cancerous cell's growth and provides comfort by relieving the patients with cancer symptoms. Cancer is the abnormal growth and spread of cells which arises from a change in a single cell. Change may be due to external agents and inherited genetic factors and can affect almost any body part. Cancer can be prevented by avoiding exposure to the common risk factors, by surgery, radiotherapy and chemotherapy. Europe has wide variances in accessing radiation therapy services, scantiness in infrastructure and skilled professionals. As per, the International Atomic Energy Agency (IAEA) report 2012, about 1286 radiotherapy centres registered in the DIRAC database in Europe. Germany has the largest number with 289 centres, France with 177, Italy with 172 centres and Spain has 117 centres respectively. Netherlands and UK along with Nordic countries (Scandinavia, Finland and Iceland) have the most centralized radiotherapy infrastructure with more treatment equipment and fewer facilities at each centre. In February 2017, Elekta and the European Society for Radiotherapy and Oncology (ESTRO) Cancer Foundation (ESF) to contribute to the mission of every patient in Europe will have access to state of the art of radiation. In June 2011, Cayman chemical company has adopted the Genedata screener of Genedata, the company of advanced software solutions for drug discovery and life science research as a data management platform for Cayman's new epigenetic screening laboratory.  


Europe Radiotherapy Market Dynamics

Radiotherapy market in Europe is driven by various factors like growing number of cancer patients, favourable non-government and government funds in R&D of cancer treatment. Furthermore, inclination towards non-invasive techniques and decreased cost of treatment in the developed areas are expected to boost the growth of the radiotherapy market in Europe. However, side effects like skin problems, fertility issues, loss of hair and appetite and also harms caused to other healthy cells because of high dosage of radiation will restrain the growth of radiotherapy market in Europe. Moreover, costs associated with training the professionals, difficulty in maintenance and up gradation of equipment are expected to hamper the Europe radiotherapy market.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Europe Radiotherapy Market Segmentation

By Equipment
  • Radiation therapy stimulators
  • Treatment planning systems
  • Linear Accelerators
By Type
  • External therapy
  • Intensity modulated therapy
  • External beam therapy
  • Image-guided radiation therapy
  • Stereotactic body radiation therapy
  • Intraoperative radiation therapy
  • Electron therapy
  • Proton Therapy
  • Tomotherapy
  • Internal therapy
  • Brachytherapy
  • Radioisotope or radionuclide therapy
  • Radioembolization
By Application
  • Skin and lip cancer
  • Head and neck cancer
  • Breast cancer
  • Prostate cancer
  • Cervical cancer
  • Lung cancer
  • Spine cancer
By End User
  • Hospitals
  • Oncology centers
  • R&D centers
  • Diagnostic centers

Frequently Asked Questions

The europe radiotherapy market size was valued at USD 5,650.2 million in 2022

Beam Applications SA RaySearch Laboratories AB Elekta AB Nordion Inc. C. R. Bard Inc. Varian Medical Systems Inc. Mevion Medical Systems Inc.

The Europe Radiotherapy Market segments are by equipment, by type, application and end user

  • Beam Applications SA
  • RaySearch Laboratories AB
  • Elekta AB
  • Nordion Inc.
  • C. R. Bard Inc.
  • Varian Medical Systems Inc.
  • Mevion Medical Systems Inc.
  • IsoRay Medical Inc.
  • Mitsubishi Electric Corporation
  • Accuray Incorporated .